{"entity":{"type":"insider","cik":"0001296543","url":"/insider/0001296543","json_url":"/insider/0001296543.json","name":"Ahn Mark J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":11,"first":"2005-01-21","last":"2015-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Ahn Mark J","source":"filing","n_filings":11,"first_seen":"2005-01-21","last_seen":"2015-08-03"}],"transactions":[{"id":8045699,"accession":"0000318306-15-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000318306-15-000039","line_url":"/filing/0000318306-15-000039#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18182.0,"shares_display":"18,182","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":100001.0,"total_display":"100,001.00","total_whole":"100,001","shares_owned_after":343182.0,"shares_owned_after_display":"343,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-31","filed_date":"2015-08-03","scope":"insider"},{"id":8626045,"accession":"0000318306-15-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000318306-15-000002","line_url":"/filing/0000318306-15-000002#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"PLASMATECH BIOPHARMACEUTICALS INC","issuer_ticker":"PTBI","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-26","filed_date":"2015-01-26","scope":"insider"},{"id":6656925,"accession":"0001250853-14-000035","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001250853-14-000035","line_url":"/filing/0001250853-14-000035#line-6","is_derivative":false,"issuer_cik":"0001296543","issuer_name":"Galena Biopharma, Inc.","issuer_ticker":"GALE","issuer_name_source":null,"issuer_url":"/issuer/0001296543","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":796765.0,"shares_display":"796,765","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":3848374.95,"total_display":"3,848,374.95","total_whole":"3,848,375","shares_owned_after":113764.0,"shares_owned_after_display":"113,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-27","filed_date":"2014-01-29","scope":"insider"},{"id":9106082,"accession":"0001422882-11-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422882-11-000011","line_url":"/filing/0001422882-11-000011#line-1","is_derivative":false,"issuer_cik":"0001296543","issuer_name":"Galena Biopharma, Inc.","issuer_ticker":"GALE","issuer_name_source":null,"issuer_url":"/issuer/0001296543","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.659,"price_display":"0.66","price_state":"stated","total_value":6590.0,"total_display":"6,590.00","total_whole":"6,590","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-07","filed_date":"2011-12-07","scope":"insider"},{"id":8977252,"accession":"0001209191-11-023604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-023604","line_url":"/filing/0001209191-11-023604#line-1","is_derivative":false,"issuer_cik":"0001296543","issuer_name":"RXI PHARMACEUTICALS CORP","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001296543","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, par value $.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":9500.0,"total_display":"9,500.00","total_whole":"9,500","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-20","filed_date":"2011-04-20","scope":"insider"},{"id":5018191,"accession":"0001179110-06-011286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-06-011286","line_url":"/filing/0001179110-06-011286#line-1","is_derivative":false,"issuer_cik":"0001140028","issuer_name":"Hana Biosciences Inc","issuer_ticker":"HNAB","issuer_name_source":null,"issuer_url":"/issuer/0001140028","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":9.07,"price_display":"9.07","price_state":"stated","total_value":49885.0,"total_display":"49,885.00","total_whole":"49,885","shares_owned_after":202744.0,"shares_owned_after_display":"202,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-17","filed_date":"2006-05-18","scope":"insider"},{"id":3769186,"accession":"0001179110-06-007208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-06-007208","line_url":"/filing/0001179110-06-007208#line-1","is_derivative":false,"issuer_cik":"0001140028","issuer_name":"Hana Biosciences Inc","issuer_ticker":"HNAB","issuer_name_source":null,"issuer_url":"/issuer/0001140028","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.63,"price_display":"10.63","price_state":"stated","total_value":10630.0,"total_display":"10,630.00","total_whole":"10,630","shares_owned_after":31877.0,"shares_owned_after_display":"31,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-24","filed_date":"2006-03-27","scope":"insider"},{"id":1412996,"accession":"0001179110-05-019947","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-05-019947","line_url":"/filing/0001179110-05-019947","is_derivative":false,"issuer_cik":"0001140028","issuer_name":"Hana Biosciences Inc","issuer_ticker":"HNAB","issuer_name_source":null,"issuer_url":"/issuer/0001140028","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10892.0,"shares_display":"10,892","price_per_share":4.59,"price_display":"4.59","price_state":"stated","total_value":49994.28,"total_display":"49,994.28","total_whole":"49,994","shares_owned_after":30877.0,"shares_owned_after_display":"30,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-19","filed_date":"2005-10-21","scope":"insider","n_lines":2},{"id":1200567,"accession":"0001179110-05-014375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-05-014375","line_url":"/filing/0001179110-05-014375#line-1","is_derivative":false,"issuer_cik":"0001140028","issuer_name":"Hana Biosciences Inc","issuer_ticker":"HNAB","issuer_name_source":null,"issuer_url":"/issuer/0001140028","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.63,"price_display":"1.63","price_state":"stated","total_value":3260.0,"total_display":"3,260.00","total_whole":"3,260","shares_owned_after":28531.0,"shares_owned_after_display":"28,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-15","filed_date":"2005-07-18","scope":"insider"},{"id":1278215,"accession":"0001179110-05-008521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-05-008521","line_url":"/filing/0001179110-05-008521","is_derivative":false,"issuer_cik":"0001140028","issuer_name":"Hana Biosciences Inc","issuer_ticker":"HNAB","issuer_name_source":null,"issuer_url":"/issuer/0001140028","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39062.0,"shares_display":"39,062","price_per_share":1.28,"price_display":"1.28","price_state":"stated","total_value":49999.36,"total_display":"49,999.36","total_whole":"49,999","shares_owned_after":26531.0,"shares_owned_after_display":"26,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-22","filed_date":"2005-04-29","scope":"insider","n_lines":2},{"id":1354807,"accession":"0001179110-05-001529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-05-001529","line_url":"/filing/0001179110-05-001529","is_derivative":false,"issuer_cik":"0001140028","issuer_name":"Hana Biosciences Inc","issuer_ticker":"HNAB","issuer_name_source":null,"issuer_url":"/issuer/0001140028","owner_cik":"0001296543","owner_name":"Ahn Mark J","owner_display_name":"Ahn Mark J","owner_url":"/insider/0001296543","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.475,"price_display":"2.48","price_state":"stated","total_value":9900.0,"total_display":"9,900.00","total_whole":"9,900","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-19","filed_date":"2005-01-21","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ABEONA THERAPEUTICS INC.","url":"/issuer/0000318306","role":"Director","n_filings":2,"first_seen":"2015-01-26","last_seen":"2015-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001390478","name":"Galena Biopharma, Inc.","url":"/issuer/0001390478","role":"Director, Officer (President & CEO)","n_filings":3,"first_seen":"2011-04-20","last_seen":"2014-01-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001140028","name":"Hana Biosciences Inc","url":"/issuer/0001140028","role":"Director, Officer (President and CEO)","n_filings":6,"first_seen":"2005-01-21","last_seen":"2006-05-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001296543","retrieved_at":"2026-08-25T04:53:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}